Drug Library | Check Interactions | Compare Drugs | Conditions & Treatments | Interactive Tools


	• Drugs & Vitamins • Herbs & Supplements • Pill Images • Using Medicine


	• Drug Comparisons • Side Effect Comparisons


	• Health Conditions • Treatment Options


	• Care Paths • Check for Savings • Health Risk Assessments • Medication Card • Medication Checklist

Health Conditions

High Cholesterol

References

American Heart Association. Heart Diseases and Stroke Statistics-2006 Update. Dallas, Texas: American Heart Association 2006. Available at: http://www.americanheart.org/downloadable/heart/1140534985281Statsupdate06book.pdf. Accessed September 12, 2006 and June 29,2007.

Edelson, E. Could a Pill Treat Obesity and Lower Cholesterol? Available at: http://www.drugdigest.org/DD/Articles/News/0,10141,514340|2,00.html

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Updated Guidelines for Cholesterol Management. JAMA 2001; 285:2486-2509.

National Cholesterol Education Program (NCEP) Report: Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004; 110: 227-239.

CDC Highlights in Minority Health: http://www.cdc.gov/omh/Highlights/2004/HSept04.htm Accessed June 29, 2007

MayoClinic.com. High blood cholesterol. Available at: http://www.mayoclinic.com/health/high-blood-cholesterol/DS00178. Accessed September 12, 2006 and June 29, 2007.

National Heart, Lung, and Blood Institute. Facts about blood cholesterol. Available at: http://www.nhlbi.nih.gov/health/dci/Diseases/Hbc/HBC_WhatIs.html. Accessed September 12, 2006 and June 29, 2007.

National Heart, Lung, and Blood Institute. High Blood Cholesterol, What you Need to Know. Available at: http://www.nhlbi.nih.gov/health/public/heart/chol/hbc_what.htm. Accessed July 18,2005 and June 29, 2007.

National Heart, Lung, and Blood Institute. Live Healthier, Live Longer. Available at: http://www.nhlbi.nih.gov/chd/. Accessed July 18,2005 and June 29, 2007 .

Talbert, RL. Hyperlipidemia. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM, editors. Pharmacotherapy A Pathophysiologic Approach. 6th ed. McGraw-Hill 2005. pg. 429-452.

The American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Dyslipidemia and Prevention of Atherosclerosis. Endocrine Practice. 2000; 6(2): 164-213.

Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Heart, Lung and Blood Institute; 2001.

Azen SP, Mack WJ, Cashin-Hemphill L, and others. Progression of coronary artery disease predicts clinical coronary events: long-term follow-up from the Cholesterol-Lowering Atherosclerosis Study. Circulation. 1996;93(1):34-41.

Blankenhorn DH, Nessim SA, Johnson RL, and others. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. The CLAS Study. Journal of the American Medical Association. 1987;257(23):3233-3240.

Brown G, Albers JJ, Fisher LD, and others. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. The FATS Study. New England Journal of Medicine. 1990;323(19):1289-1298.

Home Health Testing. Cholesterol tests. Available at: http://www.cholesterol-testing.com/. Accessed Feb 23, 2001 and July 2, 2007.

Managing hypercholesterolemia and coronary heart disease: goals for patient treatment. American Journal of Managed Care. 1997;3:S12-S17.

National Heart, Lung, and Blood Institute. Cholesterol Month September 2006. Available at: http://hin.nhlbi.nih.gov/cholmonth. Accessed September12, 2006 and June 29, 2007.

Sacks FM, Pfeffer MA, Moye LA, and others. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine. 1996;335:1001-1009.

Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease; the Scandinavian Simvastatin Survival Study (4S). The Lancet. 1994;344:1383-1389.

Shepherd J, Cobbe SM, Ford I, and others. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: the west of Scotland coronary prevention study. New England Journal of Medicine. 1995;333:1301-1307.

Simons LA, Levis G, Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Medical Journal of Australia. 1996;164:208-212.

Pearson TA, Denke MA, McBride PE, and others. A Community-Based, Randomized Trial of Ezetimibe Added to Statin therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial. The Mayo Clinic. 2005; 80(5): 587-595.

Triplitt CL, Reasner CA, Isley WL. Metabolic Syndrome heading in Diabetes Mellitus In: Dipiro, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM, editors. Pharmacotherapy A Pathophysiologic Approach. 6th ed. McGraw-Hill 2005. pg. 1341

Total Cholesterol Level Among US Adults Continues to Decline. Oct 20,2005. JAMA.2005; 294:1773-1781. Available at: http://www.sciencedaily.com/releases/2005/10/051020083530.htm . Accessed July 3, 2007

<< Back

Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.

Learn About

Introduction

What is it?

What causes it?

Who has it?

What are the risk factors?

What are the symptoms?

How is it treated?

What is on the horizon?

References